Warning Letter Tells Provident to Hire GMP Consultant

The FDA has advised Provident Pharmaceuticals to hire a good manufacturing practice (GMP) training consultant after finding its quality control unit did not follow company procedures. The FDA has concerns about Provident’s commitment to ensure GMP compliance, according to a Nov. 9 warning letter posted recently to the agency’s website. After the training, the company should evaluate all written procedures to ensure they are adequate, complete and in compliance, the letter says.
Washington Drug Letter